• Noor Rai

PET, image-guided HDAC inhibition of pediatric diffuse midline glioma improves survival in murine mo

Updated: Sep 23, 2020


Efforts at altering the dismal prognosis of pediatric midline gliomas focus on direct delivery strategies like convection-enhanced delivery (CED), where a cannula is implanted into tumor. Successful CED treatments require confirmation of tumor coverage, dosimetry, and longitudinal in vivo pharmacokinetic monitoring. These properties would be best determined clinically with image-guided dosimetry using theranostic agents. In this study, we combine CED with novel, molecular-grade positron emission tomography (PET) imaging and show how PETobinostat, a novel PET-imageable HDAC inhibitor, is effective against DIPG models. PET data reveal that CED has significant mouse-to-mouse variability; imaging is used to modulate CED infusions to maximize tumor saturation. The use of PET-guided CED results in survival prolongation in mouse models; imaging shows the need of CED to achieve high brain concentrations. This work demonstrates how personalized image-guided drug delivery may be useful in potentiating CED-based treatment algorithms and supports a foundation for clinical translation of PETobinostat.


To read the full publication please click on the following link:

https://advances.sciencemag.org/content/6/30/eabb4105/tab-pdf





13 views0 comments

UK HEADQUARTERS 

8 Neptune Court Vanguard Way

Ocean Park, Cardiff

South Glamorgan

Wales, CF24 5PJ

INQUIRIES

info@neurochase.com

+44 7507 158943

Media Center 

 © NEUROCHASE LIMITED
Company Number 12428919